335 Hospital physicians’ and older patients’ agreement with individualised STOPP/START recommendations N=70;18.9%) and 4) miscellaneous others (all other medications, N=98;26.4%). The levels of agreement with PT recommendations within these groups is displayed in Figure 5. Within these medication groups, agreement varied when stratified for gender, with significantly higher agreement in females for cardiovascular medications i.e. 66.7% versus 41.5% by males (RR 1.61; 95%CI 1.05-2.45; p=0.0274) and osteoporosis drugs i.e. 91.9% versus 54.5% (RR 1.68; 95%CI 1.21-2.33; p=0.0017). A history of ≥1 falls in the previous year resulted in significantly higher agreement with recommendations regarding osteoporosis drugs i.e. 94.6% versus 51.5% among patients with no falls (RR 1.84; 95%CI 1.31-2.58; p=0.0005). Figure 5. Categorisation of individual STOPP/START recommendations (N=371) into 5 medication groups and subsequent agreement after discussion with patient and attending physician. Note: Groups ‘psychotropics’ and ‘drugs for acid related disorders’ contain only STOPP recommendations, ‘osteoporosis agents’ 3 STOPP and 67 START, ‘cardiovascular & antithrombotic agents’ 35 STOPP and 48 START and the group ‘other’ contained 79 STOPP and 19 START recommendations. 4
RkJQdWJsaXNoZXIy MTk4NDMw